Boxer Capital’s IDEAYA Biosciences IDYA Stock Holding History

Boxer Capital’s Portfolio IDYA Stock Details IDYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-2,202,812	Closed	-$69.8M	–	19
2024 Q3	$69.8M	Hold	2,202,812	–	–	3.42%	10
2024 Q2	$77.3M	Hold	2,202,812	–	–	4.07%	8
2024 Q1	$96.7M	Hold	2,202,812	–	–	4.77%	6
2023 Q4	$78.4M	Hold	2,202,812	–	–	3.91%	12
2023 Q3	$59.4M	Hold	2,202,812	–	–	3.16%	11
2023 Q2	$51.8M	Hold	2,202,812	–	–	2.4%	13
2023 Q1	$30.2M	Hold	2,202,812	–	–	1.49%	20
2022 Q4	$40M	Hold	2,202,812	–	–	2.11%	16
2022 Q3	$32.9M	Hold	2,202,812	–	–	1.85%	19
2022 Q2	$30.4M	Hold	2,202,812	–	–	1.93%	20
2022 Q1	$24.6M	Hold	2,202,812	–	–	1.27%	23
2021 Q4	$52.1M	Hold	2,202,812	–	–	2.02%	16
2021 Q3	$56.1M	Hold	2,202,812	–	–	1.96%	11
2021 Q2	$46.2M	Hold	2,202,812	–	–	1.63%	14
2021 Q1	$51.8M	Hold	2,202,812	–	–	1.76%	12
2020 Q4	$30.8M	Hold	2,202,812	–	–	0.99%	28
2020 Q3	$27.7M	Hold	2,202,812	–	–	0.96%	31
2020 Q2	$31.3M	Buy	2,202,812 +1,438,560	+188%	+$11.3M	1.38%	26
2020 Q1	$3.15M	Hold	764,252	–	–	0.21%	55
2019 Q4	$5.73M	Hold	764,252	–	–	0.32%	44
2019 Q3	$6.88M	Hold	764,252	–	–	0.5%	37
2019 Q2	$7.61M	Buy	+764,252	New	+$8.31M	0.65%	28

Other funds holding IDYA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Boxer Capital's IDYA Position: Q4 2024 in Review

Boxer Capital sold out of IDEAYA Biosciences (IDYA) in Q4 2024, closing a stake of 2,202,812 shares — an estimated $69.8M sold.

Boxer Capital first reported a position in IDYA in Q2 2019 and held it in 22 quarters. The position peaked at $96.7M in Q1 2024. 206 funds tracked by Wall St. Rank hold IDYA as of Q4 2024.

Boxer Capital reported no remaining IDEAYA Biosciences position as of Q4 2024 after selling out during the quarter.
Boxer Capital sold 2,202,812 IDEAYA Biosciences shares in Q4 2024, an estimated $69.8M.
Boxer Capital first reported a position in IDEAYA Biosciences in Q2 2019 and held it in 22 quarters.
Boxer Capital's IDEAYA Biosciences position peaked at $96.7M in Q1 2024.
206 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q4 2024.

Based on Boxer Capital's 13F filing for Q4 2024.